下调和上调
心脏纤维化
活性氧
基因敲除
线粒体
生物
细胞生物学
纤维化
成纤维细胞
骨膜炎
表观遗传学
甲基化
SIRT2
DNA甲基化
分子生物学
线粒体ROS
化学
免疫印迹
平衡
小干扰RNA
压力过载
RNA干扰
癌症研究
信使核糖核酸
心室颤动
作者
Zhen-Yu Liu,Sui Mao,Peng Liu,Li-Chan Lin,董玲,Heng Luo,Xian-Ming Tao,Jing-Jing Yang,Jian‐Yuan Zhao,Hui Tao
摘要
AIMS: Dynamic interactions between micronuclear and mitochondrial reactive oxygen species influence micronuclear homeostasis and associated heart diseases. However, the molecular mechanisms underlying micronuclear rupture during cardiac fibrosis remain largely unknown. METHODS AND RESULTS: Cardiac fibroblast-specific YTHDF1-deficient and wild-type mice were treated with isoproterenol/transverse aortic constriction to induce cardiac fibrosis. To investigate the roles of YTHDF1, p66shc, and m6A modification in cardiac fibrosis, AAV9 vectors carrying a cardiac fibroblast-specific periostin promoter were used to induce p66shc overexpression or deliver small hairpin RNA targeting YTHDF1, along with the m6A inhibitor 3-deoxyadenosine. Histological and molecular biology analyses were conducted to examine how YTHDF1 regulates p66shc mRNA stability during cardiac fibrosis. Additionally, p66shc reconstitution in YTHDF1-deficient cardiac fibroblasts and mouse hearts was performed to assess its effects on micronuclear rupture and fibrosis. Human atrial fibrillation heart tissue was used to validate these findings.During cardiac fibrosis, the increased micronuclear rupture was accompanied by p66shc upregulation and excessive mitochondrial reactive oxygen species production. Fibroblast-specific p66shc depletion inhibited micronuclear rupture, mitochondrial reactive oxygen species, and fibroblast pyroptosis, and alleviated cardiac fibrosis. Notably, p66shc upregulation was correlated with elevated m6A modification of mRNA. Mechanistically, YTHDF1 recognized the m6A-modified site on p66shc mRNA, enhancing its stability and translation. Conversely, YTHDF1 knockdown inhibits the stability and expression of p66shc, leading to opposing effects. In human atrial fibrillation heart tissues, increased YTHDF1 and p66shc levels were associated with enhanced micronuclear rupture, excessive mitochondrial reactive oxygen species production, fibroblast pyroptosis, and cardiac fibrosis. CONCLUSIONS: This study revealed a novel epigenetic mechanism in which m6A methylation of p66shc drives micronuclear rupture and exacerbates cardiac fibrosis. These findings provide new insights into potential measures for preventing cardiac fibrosis. TRANSLATIONAL PERSPECTIVES: These findings reveal a clinically significant role of the YTHDF1/p66shc axis in mitigating cardiac fibrosis. Targeting m6A methylation of p66shc to suppress mitochondrial ROS generation, micronucleus rupture, and cardiac fibroblast pyroptosis may offer a promising therapeutic strategy for cardiac fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI